Korea to add Canada to drug price reference country this year...The domestic drug price reduction variable disappears. The reorganization of the drug price system, which was promoted by the Canadian government, has been temporarily suspended. Analysts say that the Canadian Ministry of Health officially announced that it would come up with a new reform plan due to strong opposition from the local pharmaceutical industry and that the plan to reevaluate the prices of premium drugs has virtually been canceled. Canada's move is also expected to affect South Korea's decision on the price of salaried drugs. In Korea, Canada has been added to the drug price reference country since this year.


◆ Canada's M

Kim, Jin-Gu(kjg@dailypharm.com)